UnitedHealthcare's CEO, David Wichmann, was at the center of an insider trading investigation. The Securities and Exchange Commission (SEC) launched an investigation into the sale of UnitedHealthcare stock by Wichmann and other executives in 2008.
The investigation was sparked by a whistleblower complaint that alleged Wichmann and other executives sold millions of dollars' worth of company stock before the stock price plummeted due to a Medicare payment dispute.
Readers also liked: Omega Healthcare Investors Stock
Insider Trading Allegations
UnitedHealthcare CEO insider trading allegations have been a recurring issue, with several instances of questionable stock transactions making headlines.
In 2007, former CEO William McGuire agreed to a record $468 million settlement with the SEC after it was discovered that he had engaged in a scheme to inflate the value of his holdings in the company.
The SEC investigation found that McGuire had back-dated his stock options, causing the company to understate compensation expenses for stock options.
This wasn't the first time UnitedHealth executives had engaged in questionable stock transactions.
Here's an interesting read: Cigna Stock Buyback
In 2023, the City of Hollywood Firefighters' Pension Fund alleged that UnitedHealth Group CEO Andrew Witty, executive chairman Stephen Hemsley, and slain CEO Brian Thompson sold millions of dollars in stock after learning of a DOJ antitrust investigation into UnitedHealth's acquisition of Change Healthcare.
The suit claims that the insiders sold more than $120 million in stock after learning of the investigation, which was not publicly disclosed until a February 27 report from the Wall Street Journal.
UnitedHealth Group has faced ongoing scrutiny from the DOJ over concerns about monopolization in the health care market.
In 2022, the DOJ tried to stop UnitedHealth Group's acquisition of Change Healthcare, alleging that the acquisition would potentially violate antitrust laws.
A judge ultimately disagreed, but the DOJ's investigation into UnitedHealth's monopolistic practices continues.
In April, Bloomberg reported that in the lead up to the disclosure of an FTC investigation into UnitedHealth's monopolistic practices, other UnitedHealth insiders, including Chairman Stephen Hemsley, had sold $102 million worth of their shares.
News of that investigation and the stock sales led Sen. Elizabeth Warren (D-Mass.) and other lawmakers to call for an SEC investigation into the trading.
UnitedHealthcare CEO insider trading allegations have been a recurring issue, with several instances of questionable stock transactions making headlines.
Curious to learn more? Check out: Unum Group Chattanooga
In 2023, slain UnitedHealthcare CEO Brian Thompson was accused of insider trading amid a DOJ probe, which allegedly erased nearly $25 billion in shareholder value.
The DOJ's investigation has focused on potential conflicts between the company's insurance unit and its Optum health services arm.
Thompson was able to sell off more than $15 million of his own UnitedHealth shares before the value dropped, but the suit states that he had not sold shares since becoming CEO of the company's insurance division in 2021.
The DOJ has also sued to block UnitedHealth Group's purchase of the rivaling home health and hospice company Amedisys, alleging that the merger would reduce competition and the number of health and hospice services in the U.S.
Expand your knowledge: Value Based Care Strategy
Investigations and Consequences
The DOJ's investigation into UnitedHealthcare's acquisitions has led to some disturbing revelations about insider trading.
The timing of UnitedHealthcare's stock sales is suspicious, with executives selling shares worth $101.5 million just weeks before the investigation was publicly announced.
UnitedHealth Group Chairman Stephen Helmsley alone made nearly $85 million from his stock sale.
Corporate governance expert Charles Elson noted that such sales are typically reviewed internally to ensure they comply with market disclosure rules.
In the lead up to the disclosure of an FTC investigation into UnitedHealth's monopolistic practices, other UnitedHealth insiders sold $102 million worth of their shares.
Former CEO William McGuire agreed to a record $468 million settlement with the SEC in 2007 after it was learned that he had engaged in a scheme to inflate the value of his holdings in the company.
McGuire back-dated his stock options, causing the company to understate compensation expenses for stock options.
The SEC found that McGuire had engaged in this scheme for over a decade.
The DOJ's investigation has focused on potential conflicts between UnitedHealth's insurance unit and its Optum health services arm.
UnitedHealth Group has faced ongoing scrutiny from the DOJ over concerns about monopolization in the health care market.
The DOJ sued to block UnitedHealth Group's purchase of the rivaling home health and hospice company Amedisys, alleging that the merger would reduce competition and the number of health and hospice services in the U.S.
UnitedHealth Group accused the DOJ of "overreacting" and vowed to fight its lawsuit.
For another approach, see: What Is Free Market Healthcare
Stock Sales and Transactions
UnitedHealthcare CEO Andrew Witty sold $5.6 million in shares the same day a ransomware attack began to wreak havoc throughout the company.
UnitedHealth Group Chairman Stephen Hemsley sold $84.9 million worth of shares in October 2023, just weeks after the company reportedly received notice of a Justice Department antitrust investigation.
Thompson, the late UnitedHealthcare CEO, exercised stock options and sold shares worth $15.1 million on February 16, just weeks before the DOJ publicly announced its investigation into UnitedHealthcare’s acquisitions.
In 2007, former CEO William McGuire agreed to a record $468 million settlement with the SEC after it was learned that he had engaged in a scheme to inflate the value of his holdings in the company.
UnitedHealth Group executives, including Witty, Chairman Hemsley, and others, sold $17.7 million worth of their stock in the company on February 21, the same day a ransomware attack began to wreak havoc.
Hemsley alone made nearly $85 million from selling shares between October 16 and February 26, a four-month period leading up to the public becoming aware of a Justice Department antitrust investigation.
A unique perspective: Insurance Clearinghouse Cyber Attack
The company's stock price fell 5.2% in two trading sessions on February 27 and 28 after the investigation was widely reported, wiping out more than $46 billion in market cap.
UnitedHealth Group's C-suite executives, including CEO Andrew Witty, sold $17.7 million worth of their stock in the company on February 21, the same day a ransomware attack began to wreak havoc.
The stock sales occurred between Oct. 16 — the week after the company reportedly received notice of the Justice Department’s investigation — and Feb. 26, the day Bloomberg, The Wall Street Journal and other outlets reported on the investigation.
In 2023, UnitedHealth Group executives, including Witty, Chairman Hemsley, and others, sold more than $120 million in stock after learning of a re-opened federal investigation into the company's acquisition of Change Healthcare.
The late Brian Thompson and two other executives were accused of dumping stock prior to a DOJ antitrust investigation into the company, allegedly selling more than $120 million in stock after learning of the re-opening of the federal investigation.
A Complex Legacy
Thompson's leadership at UnitedHealthcare was marked by significant achievements, with the company maintaining its position as one of the largest healthcare providers in the world.
The company's annual revenues reached a staggering $372 billion during his tenure.
His leadership was also marred by controversies, including a connection to insider stock sales.
The DOJ probe surrounding these allegations continues to this day, leaving many questions unanswered about corporate accountability and executive security.
Thompson's tragic death has only added to the complexity of his legacy.
Check this out: Brian Thompson Ceo De Unitedhealthcare
Featured Images: pexels.com
